Form 10-Q · Quarterly report
NetApp 10-Q, filed Sep 2, 2026
- Filed
- CIK
- 0001002047
- Accession no.
- 0001193125-26-380207
Summary
It reported fiscal first-quarter 2027 net revenues of $2.03 billion, up 30% from a year earlier on higher product and services revenues, and said memory and component cost inflation and supply constraints kept pressure on gross margins, prompting price increases. During the quarter NetApp acquired DataPelago, a private company focused on removing data-processing bottlenecks for AI and analytics workloads, for $193 million and recorded $56 million in restructuring charges.
Key points
- Net revenues rose 30% to $2.025 billion, with product revenues up 51% to $987 million and services revenues up 15% to $1.038 billion.
- An extra week in the quarter added about $65 million of services revenues.
- NetApp repurchased 1.5 million shares for $200 million at an average price of $133.32 and paid $102 million in dividends at $0.52 per share.
- Of the $193 million DataPelago purchase price, $87 million was paid in cash at closing, with the remainder contingent on criteria in the merger agreement.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion Overview Our Company NetApp is a global leader in intelligent data infrastructure, empowering organizations to realize the full potential of their data in a rapidly evolving digital world. Headquartered in San Jose, California, and serving customers in approximately 150 countries, NetApp delivers innovative solutions that enable seamless data management, protection, and mobility across on-premises, hybrid, and multi-cloud environments. Our flagship ONTAP® data management software, together with a comprehensive portfolio of all-flash, hybrid-flash, and cloud-native offerings, forms the foundation for customers’ digital transformation initiatives. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.